沃华医药
(002107)
| 流通市值：32.35亿 | | | 总市值：32.79亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 404,025,624.09 | 344,774,257.71 | 327,460,207.48 | 314,982,248.77 |
| 应收票据及应收账款 | 69,102,264.71 | 66,522,465.53 | 65,782,797.54 | 65,759,812.72 |
| 其中：应收票据 | 2,707,937.99 | 3,395,801.26 | 1,552,808.71 | 2,752,784.85 |
| 应收账款 | 66,394,326.72 | 63,126,664.27 | 64,229,988.83 | 63,007,027.87 |
| 应收款项融资 | 3,496,997.75 | 4,477,892.05 | 3,929,365.17 | 5,253,604.78 |
| 预付款项 | 3,839,211.85 | 2,908,012.71 | 2,205,487.95 | 3,597,615.12 |
| 其他应收款合计 | 1,815,635.33 | 11,793,033.61 | 15,669,601.19 | 15,374,604.64 |
| 存货 | 98,562,497.96 | 107,134,043.15 | 115,227,500.42 | 132,304,052.49 |
| 其他流动资产 | 4,918,796.93 | 5,508,698 | 6,578,522.76 | 6,892,182.7 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 585,761,028.62 | 543,118,402.76 | 536,853,482.51 | 544,164,121.22 |
| 非流动资产: | | | | |
| 投资性房地产 | 17,474,749.71 | 17,655,438.06 | 17,836,126.41 | 18,019,236.4 |
| 固定资产 | 346,575,022.11 | 353,401,190.89 | 360,667,316.95 | 367,768,841.22 |
| 使用权资产 | 1,822,551.77 | 2,055,420.92 | - | 70,450.4 |
| 无形资产 | 35,244,721.39 | 35,564,098.09 | 35,883,474.79 | 36,202,851.49 |
| 商誉 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 |
| 递延所得税资产 | 381,857.21 | 1,034,582.72 | 623,148.26 | 599,930.52 |
| 其他非流动资产 | 10,000 | 392,700 | 416,126 | 279,250 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 434,017,566.72 | 442,612,095.21 | 447,934,856.94 | 455,449,224.56 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,019,778,595.34 | 985,730,497.97 | 984,788,339.45 | 999,613,345.78 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 46,088,085.67 | 41,965,269.31 | 49,575,749.15 | 57,175,051.96 |
| 其中：应付票据 | - | 0 | 6,861,600.2 | 7,357,600.2 |
| 应付账款 | 46,088,085.67 | 41,965,269.31 | 42,714,148.95 | 49,817,451.76 |
| 合同负债 | 2,364,396.69 | 6,850,350.2 | 4,161,199.46 | 6,051,857.79 |
| 应付职工薪酬 | 7,301,744.32 | 9,262,176.41 | 6,549,867.06 | 8,760,694.4 |
| 应交税费 | 13,710,316.88 | 11,378,405.47 | 10,558,827.87 | 8,609,809.79 |
| 其他应付款合计 | 35,986,809.46 | 33,720,814.11 | 35,216,470.38 | 36,808,816.92 |
| 一年内到期的非流动负债 | 895,018.37 | 1,022,029.43 | - | 87,426.49 |
| 其他流动负债 | 152,675,135.81 | 138,090,788.41 | 149,187,680.17 | 162,316,511.3 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 259,021,507.2 | 242,289,833.34 | 255,249,794.09 | 279,810,168.65 |
| 非流动负债: | | | | |
| 租赁负债 | 1,063,684.4 | 1,154,729.92 | - | - |
| 长期应付职工薪酬 | 167,031.76 | 209,968.36 | 233,407.87 | 276,673.02 |
| 预计负债 | - | 0 | - | - |
| 递延收益 | 14,232,481 | 14,965,496.17 | 15,698,511.34 | 16,431,526.51 |
| 递延所得税负债 | 4,167,510.92 | 4,176,295.75 | 4,291,798.3 | 4,300,583.13 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 19,630,708.08 | 20,506,490.2 | 20,223,717.51 | 21,008,782.66 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 278,652,215.28 | 262,796,323.54 | 275,473,511.6 | 300,818,951.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,209,600 | 577,209,600 | 577,209,600 | 577,209,600 |
| 盈余公积 | 46,272,148.97 | 46,272,148.97 | 44,242,510.95 | 44,242,510.95 |
| 未分配利润 | 96,746,369.31 | 73,886,556.43 | 62,422,443.4 | 50,594,309.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 720,228,118.28 | 697,368,305.4 | 683,874,554.35 | 672,046,420.89 |
| 少数股东权益 | 20,898,261.78 | 25,565,869.03 | 25,440,273.5 | 26,747,973.58 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 741,126,380.06 | 722,934,174.43 | 709,314,827.85 | 698,794,394.47 |
| 负债和股东权益合计 | 1,019,778,595.34 | 985,730,497.97 | 984,788,339.45 | 999,613,345.78 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-26 | 2024-08-03 |
| 审计意见(境内) | | 标准无保留意见 | | |